Merck and Ridgeback Biotherapeutics will seek emergency authorization for their drug, which they say could have “a profound impact in controlling the pandemic.” International: Top News And Analysis

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

This Domain May Be For Sale

Related Posts

Leave a Reply